A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male Volunteers

NCT01243307 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuropathic Pain

Interventions

DRUG: CT327 (or placebo) followed by placebo (or CT327)

Sponsor

Creabilis SA

Collaborators

[object Object]